Clinical Trials Directory

Trials / Completed

CompletedNCT04936724

FDA Cigarette Warning Labels: Eye Tracking Study

Evaluation of the New FDA Warning Labels: Does Highlighting Lesser Known Harms of Tobacco Use Increase Attention, Recall and Knowledge of Tobacco Harms for Young Adults?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Abramson Cancer Center at Penn Medicine · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the effect of cigarette pictorial warning label content (lesser-known vs well-known risks) on visual engagement, recall, and knowledge of tobacco use harms.

Detailed description

This laboratory-based study will aim to enroll 120 current cigarette users to complete a 1-day randomized, parallel design protocol. The participants will be randomized to one of two conditions, pictorial warning labels (PWLs) with well-known or lesser-known tobacco harms. After completing a baseline questionnaire, the participants will view 4 warning labels from the assigned group and complete a follow-up questionnaire. Eye-tracking will provide data on visual processing of the warning labels and the effect of these labels on knowledge, attitudes, and beliefs about smoking will be supplemented by self-report.

Conditions

Interventions

TypeNameDescription
OTHERPictorial Warning LabelsParticipants will be randomized to one of two conditions and will view 4 pictorial warning labels from the assigned group for an eye-tracking task.

Timeline

Start date
2020-12-22
Primary completion
2021-11-19
Completion
2021-11-19
First posted
2021-06-23
Last updated
2024-07-22
Results posted
2024-04-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04936724. Inclusion in this directory is not an endorsement.